Previous COVID-19 infection, but not Long-COVID, is associated with increased adverse events following BNT162b2/Pfizer vaccination
J Infect
.
2021 Sep;83(3):381-412.
doi: 10.1016/j.jinf.2021.05.035.
Epub 2021 May 29.
Authors
Rachael Kathleen Raw
1
,
Clive Anthony Kelly
2
,
Jon Rees
3
,
Caroline Wroe
2
,
David Robert Chadwick
2
Affiliations
1
Newcastle University, United Kingdom; James Cook Universiry Hospital, United Kingdom. Electronic address: rachael.raw3@nhs.net.
2
James Cook Universiry Hospital, United Kingdom.
3
University of Sunderland.
PMID:
34062184
PMCID:
PMC8164507
DOI:
10.1016/j.jinf.2021.05.035
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
Comment
MeSH terms
BNT162 Vaccine
COVID-19 Vaccines
COVID-19*
Humans
SARS-CoV-2
Vaccination
Substances
COVID-19 Vaccines
BNT162 Vaccine